- Home
- / Surface Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Surface Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2023-09-12
Market Capitalization
$65.1 M
2023-09-12
Revenue
$30 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 59.4M | 15.4M | 126.2M | 2.7M | 30.0M |
| General and administrative expense | 16.1M | 20.6M | 23.6M | 25.1M | 24.9M |
| Operating expense total | 68.6M | 72.7M | 64.6M | 91.9M | |
| EBIT | (9.2M) | (57.4M) | 61.6M | (76.0M) | (61.9M) |
| EBIT margin, % | -15.4% | -373.5% | 48.8% | -206.2% | |
| Interest expense | 2.6M | 2.6M | 2.2M | ||
| Pre tax profit | (54.8M) | 59.3M | (78.5M) | (63.6M) | |
| Net Income | (6.6M) | (54.8M) | 59.3M | (78.5M) | (63.6M) |
| EPS | (1.1) |